We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

30 hedge funds and large institutions have $3.62M invested in AEON Biopharma Inc in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

482% more capital invested

Capital invested by funds: $623K → $3.62M (+$3M)

25% less funds holding

Funds holding: 40 → 30 (-10)

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
30
Holders Change
-10
Holders Change %
-25%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
9
Closed
10
Calls
$271K
Puts
–
Net Calls
+$271K
Net Calls Change
+$246K

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$62.5K
2
UBS Group
UBS Group
Switzerland
+$2.46K
3
Jane Street
Jane Street
New York
+$223

Top Sellers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
-$119K
2
SCM
Shaolin Capital Management
Florida
-$91.6K
3
PC
Periscope Capital
Ontario, Canada
-$82.5K
4
CF
Cantor Fitzgerald
New York
-$59.6K
5
CS
Clear Street
New York
-$27.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Clear Street
New York
$9.02K -$27.6K -44,992 -88%
UBS Group
27
UBS Group
Switzerland
$7.11K +$2.46K +4,010 +451%
LIM
28
Longfellow Investment Management
Massachusetts
$2.26K – – –
RCM
29
Robinson Capital Management
Michigan
$735 -$132 -216 -24%
Bank of America
30
Bank of America
North Carolina
$4 – – –
SCM
31
Shaolin Capital Management
Florida
– -$91.6K -917,120 Closed
CF
32
Cantor Fitzgerald
New York
– -$59.6K -596,666 Closed
CAC
33
Cowen and Company
New York
– -$23.2K -231,860 Closed
RCM
34
Radcliffe Capital Management
Pennsylvania
– -$12.2K -139,840 Closed
WAM
35
Warberg Asset Management
Illinois
– -$5.34K -53,500 Closed
RCM
36
Rivernorth Capital Management
Florida
– -$3.59K -44,868 Closed
EH
37
EMG Holdings
Connecticut
– -$2.19K -24,999 Closed
SSA
38
Schonfeld Strategic Advisors
New York
– -$1.31K -15,000 Closed
FTUS
39
Flow Traders U.S.
New York
– -$1K -10,461 Closed
1
2

AEON.WS Hedge Fund Activity: Q1 2024 in Review

30 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q1 2024, worth a combined $3.62M — up 482% from $623K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AEON.WS and 0 opened new positions — a net loss of 10 holders — while 9 trimmed existing stakes and 3 added.

The largest buyer was Wolverine Asset Management, adding an estimated $62.5K. The largest seller was Aristeia Capital, cutting an estimated $119K.

  • 30 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q1 2024, down from 40 in Q4 2023.
  • Funds reported $3.62M of AEON Biopharma Inc stock for Q1 2024, up 482% quarter-over-quarter.
  • 0 funds opened new AEON Biopharma Inc positions in Q1 2024 and 10 closed out, a net change of -10 holders.
  • The largest AEON Biopharma Inc buyer in Q1 2024 was Wolverine Asset Management, an estimated $62.5K added.
  • The largest AEON Biopharma Inc seller in Q1 2024 was Aristeia Capital, an estimated $119K sold.

Based on aggregated 13F filings for Q1 2024.